HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN

HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN was reported 486 times

HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FOETAL BIOPHYSICAL PROFILE SCORE 1 0.3333
1 ENCEPHALITIS CYTOMEGALOVIRUS 70 0.1598
2 PNEUMOTHORAX SPONTANEOUS TENSION 1 0.1429
3 CYTOMEGALOVIRUS TEST NEGATIVE 1 0.1250
4 URINE CYTOMEGALOVIRUS POSITIVE 1 0.1250
5 VIRUS URINE TEST POSITIVE 1 0.0769
6 PLACENTAL HYPERTROPHY 3 0.0750
7 ANTI-ERYTHROCYTE ANTIBODY 1 0.0714
8 MYOCARDITIS TOXOPLASMAL 1 0.0588
9 HEPATITIS B CORE ANTIGEN POSITIVE 2 0.0526
10 EPSTEIN-BARR VIRAEMIA 57 0.0514
11 CONGENITAL HEPATOMEGALY 2 0.0455
12 VASA PRAEVIA 1 0.0370
13 ANTI A ANTIBODY POSITIVE 2 0.0364
14 DELAYED HAEMOLYTIC TRANSFUSION REACTION 2 0.0339
15 RENAL TRANSPLANT FAILURE 30 0.0304
16 RENAL GRAFT LOSS 2 0.0247
17 BK VIRUS INFECTION 68 0.0201
18 CYTOMEGALOVIRUS SYNDROME 3 0.0182
19 CONGENITAL CYTOMEGALOVIRUS INFECTION 3 0.0176
20 RETINAL SCAR 8 0.0174
21 MENINGOENCEPHALITIS AMOEBIC 1 0.0172
22 CYSTITIS HAEMORRHAGIC 64 0.0159
23 CYTOMEGALOVIRUS GASTRITIS 4 0.0158
24 CYTOMEGALOVIRUS INFECTION REACTIVATION 69 0.0156
25 NEPHRECTOMY 22 0.0148
26 VIRAL MYELITIS 1 0.0145
27 CYTOMEGALOVIRUS DUODENITIS 1 0.0143
28 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 30 0.0128
29 GASTROENTERITIS ASTROVIRAL 1 0.0125
30 PNEUMONIA CYTOMEGALOVIRAL 24 0.0123
31 ANTI-ERYTHROCYTE ANTIBODY POSITIVE 1 0.0122
32 ULTRASOUND FOETAL ABNORMAL 1 0.0119
33 CYTOMEGALOVIRUS VIRAEMIA 51 0.0115
34 VIRAL UVEITIS 1 0.0103
35 HUMAN EHRLICHIOSIS 2 0.0096
36 CYTOMEGALOVIRUS CHORIORETINITIS 18 0.0092
37 PELVIC KIDNEY 1 0.0086
38 NEPHROPATHY TOXIC 90 0.0080
39 RENAL REPLACEMENT THERAPY 1 0.0078
40 BACTERIAL TOXAEMIA 1 0.0078
41 PERITONEAL EFFUSION 1 0.0074
42 ASYMPTOMATIC BACTERIURIA 1 0.0074
43 CRYPTOCOCCAL FUNGAEMIA 1 0.0070
44 UMBILICAL CORD VASCULAR DISORDER 1 0.0069
45 MENINGITIS VIRAL 9 0.0066
46 COMPLICATIONS OF TRANSPLANTED LUNG 2 0.0065
47 COOMBS DIRECT TEST POSITIVE 2 0.0064
48 COLITIS EROSIVE 1 0.0063
49 CYTOMEGALOVIRUS ANTIBODY POSITIVE 1 0.0063
50 COMBINED IMMUNODEFICIENCY 1 0.0062
51 HYPERCREATINAEMIA 2 0.0060
52 VIRAEMIA 8 0.0058
53 CRYPTOCOCCAL CUTANEOUS INFECTION 1 0.0055
54 ELECTIVE SURGERY 1 0.0054
55 BLOOD ALKALINE PHOSPHATASE 1 0.0054
56 GENERALISED OEDEMA 64 0.0052
57 C3 GLOMERULOPATHY 1 0.0048
58 CYTOMEGALOVIRUS COLITIS 11 0.0048
59 DISSEMINATED CYTOMEGALOVIRAL INFECTION 1 0.0046
60 PLACENTA ACCRETA 1 0.0046
61 KIDNEY DUPLEX 1 0.0042
62 INTUBATION 1 0.0040
63 SEPSIS SYNDROME 2 0.0040
64 CEREBRAL CALCIFICATION 1 0.0037
65 AMERICAN TRYPANOSOMIASIS 1 0.0037
66 HEPATITIS C ANTIBODY POSITIVE 1 0.0037
67 HYPOALDOSTERONISM 1 0.0036
68 PERIVENTRICULAR LEUKOMALACIA 1 0.0035
69 HELLP SYNDROME 2 0.0033
70 TRANSFUSION-RELATED ACUTE LUNG INJURY 1 0.0032
71 PARAPROTEINAEMIA 1 0.0032
72 VIRAL LOAD INCREASED 12 0.0031
73 LUNG TRANSPLANT REJECTION 2 0.0030
74 PULMONARY VENO-OCCLUSIVE DISEASE 2 0.0029
75 ACQUIRED DIAPHRAGMATIC EVENTRATION 1 0.0028
76 TOXOPLASMOSIS 3 0.0028
77 CYTOMEGALOVIRUS INFECTION 45 0.0027
78 CENTRAL NERVOUS SYSTEM LEUKAEMIA 1 0.0025
79 EPSTEIN-BARR VIRUS ANTIBODY POSITIVE 1 0.0025
80 TOXIC NEUROPATHY 1 0.0025
81 RESPIRATORY DISTRESS 68 0.0025
82 BASAL GANGLIA HAEMORRHAGE 2 0.0025
83 BREECH PRESENTATION 3 0.0024
84 MYELOSUPPRESSION 85 0.0024
85 ENTEROVIRUS INFECTION 2 0.0023
86 AUTOIMMUNE THROMBOCYTOPENIA 1 0.0023
87 IMMUNISATION 1 0.0023
88 ASPERGILLOSIS 3 0.0023
89 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 1 0.0022
90 DRUG RESISTANCE 57 0.0022
91 PULMONARY VASCULAR DISORDER 1 0.0021
92 FOETAL DEATH 11 0.0021
93 HAEMANGIOMA CONGENITAL 1 0.0021
94 TRACHEAL STENOSIS 1 0.0020
95 PREMATURE DELIVERY 30 0.0019
96 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3 0.0019
97 BRONCHOSTENOSIS 1 0.0018
98 LIFE SUPPORT 1 0.0018
99 URINARY TRACT INFECTION FUNGAL 1 0.0017
100 GRUNTING 1 0.0017
101 HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL 1 0.0016
102 BLOOD PRESSURE MEASUREMENT 1 0.0016
103 GESTATIONAL HYPERTENSION 2 0.0015
104 GUILLAIN-BARRE SYNDROME 7 0.0014
105 FOETAL HEART RATE DECELERATION ABNORMALITY 1 0.0014
106 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 3 0.0014
107 VIRAL HAEMORRHAGIC CYSTITIS 1 0.0014
108 PANCYTOPENIA 78 0.0014
109 ADENOVIRUS INFECTION 4 0.0014
110 PHIMOSIS 1 0.0014
111 DISSEMINATED CRYPTOCOCCOSIS 1 0.0013
112 MONOCLONAL IMMUNOGLOBULIN PRESENT 1 0.0013
113 FUNGAL PERITONITIS 2 0.0013
114 CHRONIC ALLOGRAFT NEPHROPATHY 1 0.0013
115 PLACENTA PRAEVIA 1 0.0013
116 LUNG DISORDER 61 0.0012
117 BOTULISM 1 0.0012
118 TRANSFUSION REACTION 1 0.0011
119 DRUG LEVEL FLUCTUATING 1 0.0011
120 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
121 SERUM SICKNESS 3 0.0011
122 NEONATAL RESPIRATORY DISTRESS 1 0.0011
123 PNEUMONIA CRYPTOCOCCAL 1 0.0011
124 MECHANICAL VENTILATION 2 0.0011
125 CONTINUOUS HAEMODIAFILTRATION 1 0.0010
126 TRANSPLANT REJECTION 8 0.0010
127 PREMATURE BABY 30 0.0010
128 LYMPHOPENIA 14 0.0010
129 PATHOGEN RESISTANCE 9 0.0010
130 POLYHYDRAMNIOS 1 0.0010
131 GENOTYPE DRUG RESISTANCE TEST POSITIVE 1 0.0010
132 MULTIPLE-DRUG RESISTANCE 3 0.0010
133 HEART TRANSPLANT REJECTION 1 0.0010
134 BLAST CELL COUNT INCREASED 1 0.0010
135 PNEUMONIA VIRAL 3 0.0009
136 PNEUMONIA STREPTOCOCCAL 1 0.0009
137 RETINAL DETACHMENT 8 0.0009
138 CEREBRAL VENTRICLE DILATATION 1 0.0009
139 DERMATITIS EXFOLIATIVE GENERALISED 3 0.0009
140 BONE MARROW TOXICITY 1 0.0008
141 HAEMATOTOXICITY 8 0.0008
142 VENOOCCLUSIVE DISEASE 2 0.0008
143 SYSTEMIC CANDIDA 2 0.0008
144 WHITE MATTER LESION 1 0.0008
145 BRONCHIAL SECRETION RETENTION 1 0.0008
146 MATERNAL DRUGS AFFECTING FOETUS 6 0.0008
147 OBLITERATIVE BRONCHIOLITIS 1 0.0008
148 LYMPHOCYTE PERCENTAGE DECREASED 1 0.0007
149 BRONCHIAL OBSTRUCTION 1 0.0007
150 PREMATURE LABOUR 4 0.0007
151 DIABETES MELLITUS NON-INSULIN-DEPENDENT 1 0.0007
152 CAESAREAN SECTION 8 0.0007
153 GASTROINTESTINAL WALL THICKENING 1 0.0007
154 FOETAL GROWTH RESTRICTION 4 0.0007
155 PARAINFLUENZAE VIRUS INFECTION 1 0.0007
156 IDIOPATHIC THROMBOCYTOPENIC PURPURA 1 0.0006
157 PRE-ECLAMPSIA 3 0.0006
158 PNEUMONIA LEGIONELLA 1 0.0006
159 CRYPTOCOCCOSIS 1 0.0006
160 ASPERGILLUS INFECTION 4 0.0006
161 VENOOCCLUSIVE LIVER DISEASE 3 0.0006
162 OLIGOHYDRAMNIOS 2 0.0006
163 KIDNEY FIBROSIS 1 0.0006
164 PULMONARY TOXICITY 4 0.0006
165 EXPOSURE DURING PREGNANCY 35 0.0006
166 LIVER TRANSPLANT REJECTION 1 0.0006
167 PNEUMOMEDIASTINUM 1 0.0006
168 PULMONARY ALVEOLAR HAEMORRHAGE 3 0.0005
169 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4 0.0005
170 JAUNDICE NEONATAL 1 0.0005
171 LYMPHADENOPATHY MEDIASTINAL 1 0.0005
172 HAEMOLYSIS 4 0.0005
173 TRAUMATIC LUNG INJURY 1 0.0005
174 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
175 RHINOVIRUS INFECTION 2 0.0005
176 OCCULT BLOOD POSITIVE 1 0.0005
177 PNEUMONIA STAPHYLOCOCCAL 1 0.0005
178 ACUTE KIDNEY INJURY 76 0.0005
179 HYPOSPADIAS 1 0.0005
180 GASTROENTERITIS 7 0.0005
181 CATHETER SITE ERYTHEMA 1 0.0005
182 GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0005
183 PARESIS 1 0.0004
184 CHOLESTATIC LIVER INJURY 1 0.0004
185 MENINGITIS ASEPTIC 2 0.0004
186 COMPLICATIONS OF TRANSPLANTED KIDNEY 1 0.0004
187 NEPHROPATHY 4 0.0004
188 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
189 GRAFT VERSUS HOST DISEASE 3 0.0004
190 KIDNEY TRANSPLANT REJECTION 2 0.0004
191 PREMATURE RUPTURE OF MEMBRANES 1 0.0004
192 CYTOPENIA 5 0.0004
193 STEM CELL TRANSPLANT 1 0.0004
194 URINARY TRACT INFECTION BACTERIAL 1 0.0004
195 ANGLE CLOSURE GLAUCOMA 1 0.0004
196 HAEMORRHAGIC STROKE 3 0.0004
197 EXFOLIATIVE RASH 1 0.0004
198 LUNG OPACITY 1 0.0004
199 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
200 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
201 LUNG CONSOLIDATION 1 0.0004
202 ENDOTRACHEAL INTUBATION 1 0.0004
203 BACTERAEMIA 4 0.0003
204 BRAIN HERNIATION 1 0.0003
205 URINE ANALYSIS ABNORMAL 1 0.0003
206 ATYPICAL PNEUMONIA 1 0.0003
207 BRAIN DEATH 1 0.0003
208 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
209 IRIDOCYCLITIS 1 0.0003
210 FAECAL CALPROTECTIN INCREASED 1 0.0003
211 STUPOR 1 0.0003
212 BACTERIAL SEPSIS 1 0.0003
213 HEPATIC NEOPLASM 1 0.0003
214 HEPATOMEGALY 3 0.0003
215 NEAR DEATH EXPERIENCE 1 0.0003
216 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 1 0.0003
217 WOUND DEHISCENCE 1 0.0003
218 BONE MARROW FAILURE 6 0.0003
219 FOETAL EXPOSURE DURING PREGNANCY 24 0.0003
220 MATERNAL EXPOSURE BEFORE PREGNANCY 2 0.0003
221 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 16 0.0003
222 HYPERREFLEXIA 1 0.0003
223 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
224 NEONATAL RESPIRATORY DISTRESS SYNDROME 1 0.0003
225 LUNG TRANSPLANT 1 0.0003
226 LEUKOPENIA 14 0.0003
227 AMYLASE INCREASED 1 0.0003
228 PULMONARY HAEMORRHAGE 2 0.0003
229 PNEUMONIA FUNGAL 1 0.0003
230 CANDIDIASIS 1 0.0002
231 EXTRAVASATION 1 0.0002
232 LUNG INFILTRATION 2 0.0002
233 ILEUS PARALYTIC 1 0.0002
234 HAEMOLYTIC ANAEMIA 2 0.0002
235 IRON DEFICIENCY 1 0.0002
236 SUSPECTED OFF LABEL USE 1 0.0002
237 BREATH SOUNDS ABNORMAL 1 0.0002
238 HYPERVOLAEMIA 1 0.0002
239 DERMATITIS EXFOLIATIVE 1 0.0002
240 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
241 KLEBSIELLA INFECTION 1 0.0002
242 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
243 MALABSORPTION 1 0.0002
244 RENAL IMPAIRMENT 16 0.0002
245 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
246 DEAFNESS UNILATERAL 1 0.0002
247 TREATMENT FAILURE 15 0.0002
248 ELECTROLYTE IMBALANCE 2 0.0002
249 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
250 HYPOVOLAEMIA 1 0.0002
251 OFF LABEL USE 146 0.0002
252 RESPIRATORY FAILURE 12 0.0002
253 INFUSION SITE EXTRAVASATION 1 0.0002
254 INFUSION SITE SWELLING 1 0.0002
255 PROTEINURIA 3 0.0002
256 PERITONITIS 3 0.0001
257 ENCEPHALITIS 1 0.0001
258 MENTAL STATUS CHANGES 4 0.0001
259 LARGE INTESTINE PERFORATION 1 0.0001
260 RIGHT VENTRICULAR FAILURE 1 0.0001
261 RETINAL HAEMORRHAGE 1 0.0001
262 PRODUCT SUPPLY ISSUE 1 0.0001
263 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
264 PSYCHIATRIC SYMPTOM 1 0.0001
265 HEPATOTOXICITY 3 0.0001
266 HAEMORRHAGE INTRACRANIAL 2 0.0001
267 PLEURAL EFFUSION 8 0.0001
268 LIPASE INCREASED 1 0.0001
269 SHOCK 3 0.0001
270 GASTROINTESTINAL INFLAMMATION 1 0.0001
271 THROMBOCYTOPENIA 14 0.0001
272 BLOOD DISORDER 1 0.0001
273 SHOCK HAEMORRHAGIC 1 0.0001
274 ESCHERICHIA INFECTION 1 0.0001
275 DRUG LEVEL INCREASED 2 0.0001
276 PERICARDITIS 2 0.0001
277 HEPATITIS 3 0.0001
278 PRODUCT USE ISSUE 22 0.0001
279 NEUROTOXICITY 2 0.0001
280 THERAPY NON-RESPONDER 5 0.0001
281 DEVELOPMENTAL DELAY 1 0.0001
282 PNEUMONIA BACTERIAL 1 0.0001
283 ANAPHYLACTIC REACTION 6 0.0001
284 BLOOD CREATININE INCREASED 7 0.0001
285 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
286 THROMBOTIC MICROANGIOPATHY 1 0.0001
287 RESPIRATORY DISORDER 3 0.0001
288 DRUG INEFFECTIVE 132 0.0001
289 EMPHYSEMA 1 0.0001
290 LIVER FUNCTION TEST INCREASED 2 0.0001
291 SEPTIC SHOCK 4 0.0001
292 PULMONARY THROMBOSIS 1 0.0001
293 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
294 PERICARDIAL EFFUSION 2 0.0001
295 NEOPLASM PROGRESSION 3 0.0001
296 SPLENOMEGALY 1 0.0001
297 HYPOXIA 3 0.0001
298 MYOCLONUS 1 0.0001
299 ADRENAL INSUFFICIENCY 1 0.0001
300 CARDIOMEGALY 1 0.0001
301 NEUTROPENIA 11 0.0001
302 ORAL CANDIDIASIS 1 0.0001
303 IMMUNE SYSTEM DISORDER 1 0.0001
304 PULMONARY CONGESTION 1 0.0001
305 PNEUMONITIS 2 0.0001
306 PRODUCT USE IN UNAPPROVED INDICATION 18 0.0001
307 VISUAL IMPAIRMENT 9 0.0001
308 FLUID OVERLOAD 1 0.0001
309 ANAEMIA 13 0.0001
310 ASCITES 2 0.0001
311 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
312 LUNG INFECTION 1 0.0001
313 THERAPY PARTIAL RESPONDER 1 0.0001
314 NERVOUS SYSTEM DISORDER 2 0.0001
315 SEPSIS 7 0.0001
316 DRUG INTOLERANCE 6 0.0001
317 VENTRICULAR TACHYCARDIA 1 0.0001
318 RENAL FAILURE 8 0.0001
319 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
320 HEMIPARESIS 1 0.0001
321 CIRCULATORY COLLAPSE 1 0.0001
322 HAEMATURIA 2 0.0001
323 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
324 MULTI-ORGAN FAILURE 1 0.0001
325 ORTHOSTATIC HYPOTENSION 1 0.0001
326 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
327 HYPERKALAEMIA 2 0.0001
328 LEUKOCYTOSIS 1 0.0001
329 HEPATIC FUNCTION ABNORMAL 2 0.0001
330 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
331 POST PROCEDURAL COMPLICATION 1 0.0001
332 PYREXIA 18 0.0001
333 ACUTE RESPIRATORY FAILURE 1 0.0001
334 EAR PAIN 1 0.0001
335 CHILLS 6 0.0001
336 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
337 HAEMATOCRIT DECREASED 1 0.0001
338 PREGNANCY 1 0.0000
339 ABORTION SPONTANEOUS 2 0.0000
340 BODY TEMPERATURE INCREASED 1 0.0000
341 HAEMOGLOBIN DECREASED 5 0.0000
342 PULMONARY HYPERTENSION 1 0.0000
343 CARDIO-RESPIRATORY ARREST 2 0.0000
344 MOUTH ULCERATION 1 0.0000
345 DEEP VEIN THROMBOSIS 3 0.0000
346 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
347 INFUSION RELATED REACTION 3 0.0000
348 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
349 SKIN DISCOLOURATION 2 0.0000
350 HYPOKALAEMIA 2 0.0000
351 PULMONARY EMBOLISM 4 0.0000
352 BLOOD PRESSURE FLUCTUATION 1 0.0000
353 ENCEPHALOPATHY 1 0.0000
354 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
355 PNEUMONIA ASPIRATION 1 0.0000
356 ABDOMINAL PAIN LOWER 1 0.0000
357 FLUID RETENTION 2 0.0000
358 UNRESPONSIVE TO STIMULI 1 0.0000
359 RASH GENERALISED 1 0.0000
360 HAEMATOMA 1 0.0000
361 BLOOD BILIRUBIN INCREASED 1 0.0000
362 THROAT TIGHTNESS 1 0.0000
363 PALLOR 1 0.0000
364 TREATMENT NONCOMPLIANCE 2 0.0000
365 HYPONATRAEMIA 2 0.0000
366 LIVER FUNCTION TEST ABNORMAL 1 0.0000
367 DISEASE PROGRESSION 4 0.0000
368 RENAL INJURY 1 0.0000
369 DRUG-INDUCED LIVER INJURY 1 0.0000
370 STAPHYLOCOCCAL INFECTION 1 0.0000
371 FUNGAL INFECTION 1 0.0000
372 FLUSHING 3 0.0000
373 HEPATIC ENZYME INCREASED 2 0.0000
374 GASTRIC DISORDER 1 0.0000
375 C-REACTIVE PROTEIN INCREASED 1 0.0000
376 DYSARTHRIA 1 0.0000
377 COLITIS 1 0.0000
378 CARDIAC ARREST 2 0.0000
379 RENAL FAILURE ACUTE 1 0.0000
380 BALANCE DISORDER 2 0.0000
381 VAGINAL HAEMORRHAGE 1 0.0000
382 COLITIS ULCERATIVE 1 0.0000
383 PULMONARY OEDEMA 1 0.0000
384 NO ADVERSE EVENT 4 0.0000
385 NEPHROLITHIASIS 1 0.0000
386 RASH ERYTHEMATOUS 1 0.0000
387 BLOOD PRESSURE INCREASED 3 0.0000
388 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
389 HAEMORRHAGE 2 0.0000
390 DRUG INTERACTION 3 0.0000
391 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
392 PLATELET COUNT DECREASED 2 0.0000
393 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
394 OEDEMA 1 0.0000
395 HAEMATOCHEZIA 1 0.0000
396 OXYGEN SATURATION DECREASED 1 0.0000
397 CONVULSION 1 0.0000
398 LETHARGY 1 0.0000
399 SEIZURE 2 0.0000
400 BONE PAIN 1 0.0000
401 IRRITABILITY 1 0.0000
402 OEDEMA PERIPHERAL 2 0.0000
403 FEELING HOT 1 0.0000
404 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
405 CHEST PAIN 3 0.0000
406 PNEUMONIA 5 0.0000
407 FEBRILE NEUTROPENIA 1 0.0000
408 HYPOTENSION 3 0.0000
409 MEMORY IMPAIRMENT 2 0.0000
410 SLEEP DISORDER 1 0.0000
411 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
412 DIARRHOEA 9 0.0000
413 VOMITING 6 0.0000
414 HEADACHE 8 0.0000
415 PARAESTHESIA 2 0.0000
416 CONFUSIONAL STATE 2 0.0000
417 TOXICITY TO VARIOUS AGENTS 2 0.0000
418 SKIN EXFOLIATION 1 0.0000
419 URINARY TRACT INFECTION 2 0.0000
420 TACHYCARDIA 1 0.0000
421 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
422 GASTROINTESTINAL DISORDER 1 0.0000
423 HYPERSENSITIVITY 2 0.0000
424 NEUROPATHY PERIPHERAL 1 0.0000
425 GAIT DISTURBANCE 2 0.0000
426 NAUSEA 8 0.0000
427 CONDITION AGGRAVATED 3 0.0000
428 ABDOMINAL DISTENSION 1 0.0000
429 DYSPNOEA 5 0.0000
430 DEHYDRATION 1 0.0000
431 PRODUCT QUALITY ISSUE 1 0.0000
432 WEIGHT DECREASED 2 0.0000
433 ANXIETY 2 0.0000
434 INFECTION 1 0.0000
435 MALAISE 3 0.0000
436 TREMOR 1 0.0000
437 FALL 2 0.0000
438 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
439 MUSCLE SPASMS 1 0.0000
440 HYPERTENSION 1 0.0000
441 ABDOMINAL PAIN 1 0.0000
442 COUGH 1 0.0000
443 DEATH 3 0.0000
444 PAIN IN EXTREMITY 1 0.0000
445 ASTHENIA 1 0.0000
446 PRURITUS 1 0.0000
447 RASH 1 0.0000
448 PAIN 1 0.0000